Oncostability: stability of reconstituted and diluted anticancer medicines for a possible extension of use

Marco Chiumente; Melania Rivano; Debora Severino; Sara Bertoli; Anna Rita Gasbarro; Rossella Santeramo; Alessandra Pasqualini; Riccardo Provasi; Daniele Mengato; Angelo Claudio Palozzo

doi:10.1136/ejhpharm-2021-003157

Article info

PostScript

Letter

Oncostability: stability of reconstituted and diluted anticancer medicines for a possible extension of use

Authors

Marco Chiumente Scientific Direction, Italian Society for Clinical Pharmacy and Therapeutics, Milan, Italy PubMed articles Google scholar articles
Melania Rivano Clinical Oncology Pharmacy, Azienda Ospedaliera Brotzu, Cagliari, Italy PubMed articles Google scholar articles
Debora Severino Hospital Pharmacy Department, Ausl Modena, Modena, Italy PubMed articles Google scholar articles
Sara Bertoli Department of Pharmacy, IRCCS National Cancer Institute, Milano, Lombardia, Italy PubMed articles Google scholar articles
Anna Rita Gasbarro Hospital Pharmacy Department, University Hospital Policlinico, Bari, Italy PubMed articles Google scholar articles
Rossella Santeramo Hospital Pharmacy Department, University Hospital Policlinico, Bari, Italy PubMed articles Google scholar articles
Alessandra Pasqualini Hospital Pharmacy Department, S.Chiara Hospital, Trento, Italy PubMed articles Google scholar articles
Riccardo Provasi Azienda Sanitaria Universitaria Integrata Giuliano Isontina, Trieste, Italy PubMed articles Google scholar articles
Daniele Mengato Hospital Pharmacy Department, Azienda Ospedale – Università of Padova, Padova, Italy PubMed articles Google scholar articles
Angelo Claudio Palozzo Presidency, SIFaCT President, Italian Society for Clinical Pharmacy and Therapy, Milano, Italy PubMed articles Google scholar articles

Correspondence to Dr Melania Rivano, Clinical Oncology Pharmacy, Azienda Ospedaliera Brotzu, Cagliari 09134, Sardegna, Italy; melania.rivano{at}gmail.com

View Full Text

Citation

Chiumente M, Rivano M, Severino D, et al

Oncostability: stability of reconstituted and diluted anticancer medicines for a possible extension of use

European Journal of Hospital Pharmacy 2023;30:e112.

Publication history

First published December 15, 2021.

Online issue publication

March 20, 2023

Article Versions

Previous version (20 March 2023).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password